Innoviva (INVA) Assets (2010 - 2026)
Innoviva (INVA) reported Assets of $1.8 billion for Q1 2026, up 46.41% on a YoY basis from $1.3 billion in Q1 2025, and up 12.32% quarter-over-quarter from $1.6 billion in Q4 2025.
Innoviva (INVA) Assets (2010 - 2026) Analysis & Trends
Innoviva has reported Assets for 17 years, with the latest figure at $1.8 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets rose 46.41% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (up 46.41% YoY), and the FY2025 full-year result was $1.6 billion, up 25.68% from the prior year.
- Assets for Q1 2026 stood at $1.8 billion, up from $1.6 billion in the prior quarter.
- The five-year high for Assets was $1.8 billion in Q1 2026, with the low at $1.1 billion in Q1 2022.
- Historically, Assets has averaged $1.3 billion across 5 years, with a median of $1.2 billion in 2023.
- Annual changes were most pronounced in 2022 — Assets soared 49.65% — and 2023, when it declined 10.51%.
- Innoviva's Assets stood at $1.2 billion in 2022, then increased by 0.98% to $1.2 billion in 2023, then increased by 4.63% to $1.3 billion in 2024, then climbed by 25.68% to $1.6 billion in 2025, then rose by 12.32% to $1.8 billion in 2026.
- The last three Assets figures came in at $1.8 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 33.89 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 23.64 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 640.56 Mn |
| 10 | Innoviva | 1.69 Bn | 1.08 Bn | 75.83 Mn | 1.84 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.84 Bn |
| Dec 31, 2025 | 1.64 Bn |
| Sep 30, 2025 | 1.43 Bn |
| Jun 30, 2025 | 1.33 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.27 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 1.11 Bn |
| Dec 31, 2021 | 926.40 Mn |
| Sep 30, 2021 | 887.24 Mn |
| Jun 30, 2021 | 789.15 Mn |